| For: | Handa P, Vemulakonda A, Kowdley KV, Uribe M, Méndez-Sánchez N. Mitochondrial DNA from hepatocytes as a ligand for TLR9: Drivers of nonalcoholic steatohepatitis? World J Gastroenterol 2016; 22(31): 6965-6971 [PMID: 27610009 DOI: 10.3748/wjg.v22.i31.6965] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v22/i31/6965.htm |
| Number | Citing Articles |
| 1 |
Jonas M. McCaffrey, Jamal A. Ibdah. Effects of Diet and Exercise on Mitochondrial Health in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): Role of Ceramides. Nutrients 2025; 17(18) doi: 10.3390/nu17182972
|
| 2 |
Ignazio Grattagliano, Liliana P. Montezinho, Paulo J. Oliveira, Gema Frühbeck, Javier Gómez-Ambrosi, Fabrizio Montecucco, Federico Carbone, Mariusz R. Wieckowski, David Q.-H. Wang, Piero Portincasa. Targeting mitochondria to oppose the progression of nonalcoholic fatty liver disease. Biochemical Pharmacology 2019; 160 doi: 10.1016/j.bcp.2018.11.020
|
| 3 |
Azalia Mariel Carranza-Trejo, Vaclav Vetvicka, Lucie Vistejnova, Milena Kralickova, Edgar B. Montufar. Hepatocyte and immune cell crosstalk in non-alcoholic fatty liver disease. Expert Review of Gastroenterology & Hepatology 2021; 15(7) doi: 10.1080/17474124.2021.1887730
|
| 4 |
Afshan N Malik, Inês C.M. Simões, Hannah S. Rosa, Safa Khan, Agnieszka Karkucinska-Wieckowska, Mariusz R. Wieckowski. A Diet Induced Maladaptive Increase in Hepatic Mitochondrial DNA Precedes OXPHOS Defects and May Contribute to Non-Alcoholic Fatty Liver Disease. Cells 2019; 8(10) doi: 10.3390/cells8101222
|
| 5 |
E. S. Ershova, M. S. Konkova, E. M. Malinovskaya, S. I. Kutsev, N. N. Veiko, S. V. Kostyuk. Noncanonical Functions of the Human Ribosomal Repeat. Russian Journal of Genetics 2020; 56(1) doi: 10.1134/S1022795420010044
|
| 6 |
Hui Han, Romain Desert, Sukanta Das, Zhuolun Song, Dipti Athavale, Xiaodong Ge, Natalia Nieto. Danger signals in liver injury and restoration of homeostasis. Journal of Hepatology 2020; 73(4) doi: 10.1016/j.jhep.2020.04.033
|
| 7 |
Igor Maricic, Idania Marrero, Akiko Eguchi, Ryota Nakamura, Casey D Johnson, Suryasarathi Dasgupta, Carolyn D Hernandez, Phirum Sam Nguyen, Austin D Swafford, Rob Knight, Ariel E Feldstein, Rohit Loomba, Vipin Kumar. Differential Activation of Hepatic Invariant NKT Cell Subsets Plays a Key Role in Progression of Nonalcoholic Steatohepatitis. The Journal of Immunology 2018; 201(10) doi: 10.4049/jimmunol.1800614
|
| 8 |
Lili Yu, Feifei Gao, Yaoxin Li, Dan Su, Liping Han, Yueming Li, Xuehan Zhang, Zhiwei Feng. Role of pattern recognition receptors in the development of MASLD and potential therapeutic applications. Biomedicine & Pharmacotherapy 2024; 175 doi: 10.1016/j.biopha.2024.116724
|
| 9 |
Irina V. Kholodenko, Konstantin N. Yarygin. Hepatic Macrophages as Targets for the MSC-Based Cell Therapy in Non-Alcoholic Steatohepatitis. Biomedicines 2023; 11(11) doi: 10.3390/biomedicines11113056
|
| 10 |
Barbora Vlková, Marta Kalousová, Anna Germanová, Antonín Pařízek, Zdeněk Hájek, Tomáš Zima, Peter Celec. Cell-free DNA is higher and more fragmented in intrahepatic cholestasis of pregnancy. Prenatal Diagnosis 2016; 36(12) doi: 10.1002/pd.4952
|
| 11 |
Siham Accacha, Julia Barillas-Cerritos, Ankita Srivastava, Frances Ross, Wendy Drewes, Shelly Gulkarov, Joshua De Leon, Allison B. Reiss. From Childhood Obesity to Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) and Hyperlipidemia Through Oxidative Stress During Childhood. Metabolites 2025; 15(5) doi: 10.3390/metabo15050287
|
| 12 |
Raghu Ramanathan, Ahmad Hassan Ali, Jamal A. Ibdah. Mitochondrial Dysfunction Plays Central Role in Nonalcoholic Fatty Liver Disease. International Journal of Molecular Sciences 2022; 23(13) doi: 10.3390/ijms23137280
|
| 13 |
Kris Genelyn Dimasuay, Bruce Berg, Niccolette Schaunaman, Hong Wei Chu. Role of Myeloid Cell-Specific TLR9 in Mitochondrial DNA-Induced Lung Inflammation in Mice. International Journal of Molecular Sciences 2023; 24(2) doi: 10.3390/ijms24020939
|
| 14 |
Mona M. Saber, Nada Monir, Azza S. Awad, Marwa E. Elsherbiny, Hala F. Zaki. TLR9: A friend or a foe. Life Sciences 2022; 307 doi: 10.1016/j.lfs.2022.120874
|
| 15 |
Archana Tewari, Sangam Rajak, Sana Raza, Pratima Gupta, Bandana Chakravarti, Jyotika Srivastava, Chandra P. Chaturvedi, Rohit A. Sinha. Targeting Extracellular RNA Mitigates Hepatic Lipotoxicity and Liver Injury in NASH. Cells 2023; 12(14) doi: 10.3390/cells12141845
|
| 16 |
Yu-Hong Fan, Siyao Zhang, Ye Wang, Hongni Wang, Hongliang Li, Lan Bai. Inter-organ metabolic interaction networks in non-alcoholic fatty liver disease. Frontiers in Endocrinology 2025; 15 doi: 10.3389/fendo.2024.1494560
|
| 17 |
Chander K. Negi, Sabbir Khan, Hubert Dirven, Lola Bajard, Luděk Bláha. Flame Retardants-Mediated Interferon Signaling in the Pathogenesis of Nonalcoholic Fatty Liver Disease. International Journal of Molecular Sciences 2021; 22(8) doi: 10.3390/ijms22084282
|
| 18 |
Li Xiang, Yaru Shao, Yuping Chen. Mitochondrial dysfunction and mitochondrion-targeted therapeutics in liver diseases. Journal of Drug Targeting 2021; 29(10) doi: 10.1080/1061186X.2021.1909051
|
| 19 |
Sabine Mihm. Danger-Associated Molecular Patterns (DAMPs): Molecular Triggers for Sterile Inflammation in the Liver. International Journal of Molecular Sciences 2018; 19(10) doi: 10.3390/ijms19103104
|
| 20 |
Lan Bai, Hongliang Li. Innate immune regulatory networks in hepatic lipid metabolism. Journal of Molecular Medicine 2019; 97(5) doi: 10.1007/s00109-019-01765-1
|